In this video, pathologist Dr. Jared Gardner provides a concise, high-level overview of molecular testing for a non-specialist audience. He explains the primary clinical applications: resolving difficult differential diagnoses, confirming a diagnosis when treatment or prognosis is significant, and obtaining therapeutic information, such as identifying BRAF mutations in melanoma. The presentation covers the main types of genetic abnormalities found in tumors, including point mutations, gene fusions (rearrangements), amplifications, and deletions. Dr. Gardner then outlines the corresponding testing methods used to detect them, such as sequencing for point mutations and Fluorescence In Situ Hybridization (FISH) for larger structural changes, while also touching on Next-Generation Sequencing (NGS) as a comprehensive panel. The concepts are illustrated with practical clinical examples, including the use of FISH to differentiate dermatofibroma from DFSP and the role of sequencing in guiding targeted therapy for metastatic melanoma.
A Pathologist's Guide to Molecular Testing: Key Concepts and Applications
0:48 Primary Uses of Molecular Testing: Dr. Gardner explains that molecular testing is crucial in three main scenarios:
Differential Diagnosis: To definitively distinguish between two morphologically similar tumors.
Diagnostic Confirmation: To be "iron-clad certain" about a diagnosis that has major implications for a patient's treatment or prognosis.
Therapeutic Guidance: To identify specific genetic targets for therapy, such as BRAF analysis in melanoma, which is often requested by oncologists.
1:33 Key Genetic Abnormalities: The video outlines the main types of genetic changes that these tests look for.
Point Mutations: A single nucleotide change in a gene.
Gene Fusions/Rearrangements: Two separate genes break apart and fuse, creating a new, novel "chimeric" gene that can drive tumor growth. This is important in sarcomas and certain melanocytic lesions.
Amplifications: The presence of multiple extra copies of a specific gene.
Deletions: The loss of a segment of a chromosome, including the genes it contains.
5:06 Overview of Testing Methods: Different laboratory tests are designed to detect different types of abnormalities, and choosing the right test for the suspected abnormality is critical.
5:27 Fluorescence In Situ Hybridization (FISH): This is a visual technique that uses fluorescent probes to "light up" specific genes or chromosome regions. It is excellent for detecting large structural changes like fusions, amplifications, and deletions. Key takeaway: FISH cannot detect tiny point mutations.
7:43 Sequencing: This method reads the genetic code nucleotide by nucleotide. It is the primary method used to identify small-scale changes like point mutations (e.g., the BRAF V600E mutation).
8:04 Next-Generation Sequencing (NGS): A powerful and complex method that can test for many different genes and types of abnormalities all at once. Caveats include cost, availability, and the fact that different NGS "panels" test for different sets of genes.
11:36 Clinical Example 1: Differentiating Tumors: In cases where it is difficult to distinguish a benign dermatofibroma from a malignant DFSP, a FISH test can be performed. Since DFSP has a characteristic gene fusion, a negative FISH test can rule it out and help a patient avoid a major, unnecessary surgery.
13:38 Clinical Example 2: Guiding Therapy: A patient with metastatic melanoma underwent sequencing to check for a BRAF mutation. The test was positive, allowing oncologists to use a targeted BRAF inhibitor therapy, which resulted in a complete clinical response for the patient.